Literature DB >> 22632541

Analysis of cytokines in the peritoneal fluid of endometriosis patients as a function of the menstrual cycle stage using the Bio-Plex® platform.

Nick A Bersinger1, Hervé Dechaud, Brett McKinnon, Michael D Mueller.   

Abstract

OBJECTIVE: Endometriosis is a painful disease affecting 10-15% of reproductive-age women. Concentrations of several cytokines and angiogenic factors in peritoneal fluid (PF) have been found to correlate with the severity of the disease. However, levels of some analytes vary across the menstrual cycle, and an ideal biomarker of endometriosis has not yet been identified. We have compared the PF concentrations of different cytokines in proliferative and secretory phases in women with and without the disease using the Bio-Plex platform.
METHODS: PF was aspirated during laparoscopy (N = 133) and the PF concentrations of 18 cytokines from Bio-Plex panels I and II determined with the serum protocol.
RESULTS: Increased PF concentrations of IL-6, IL-18, eotaxin, and MCP-1 were found in endometriosis with no changes with menstrual cycle. Levels of IL-12(p70), ICAM-1, and GRO-α were higher in the secretory phase, while eotaxin concentrations were lower.
CONCLUSION: Of the 18 cytokines tested, IL-6, IL-18 and MCP-1 were the best PF markers of endometriosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22632541     DOI: 10.3109/13813455.2012.687003

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  9 in total

Review 1.  Endometriosis: where are we and where are we going?

Authors:  Alexis D Greene; Stephanie A Lang; Jessica A Kendziorski; Julie M Sroga-Rios; Thomas J Herzog; Katherine A Burns
Journal:  Reproduction       Date:  2016-05-10       Impact factor: 3.906

2.  Intrafollicular inflammatory cytokines but not steroid hormone concentrations are increased in naturally matured follicles of women with proven endometriosis.

Authors:  Gengxiang Wu; N A Bersinger; M D Mueller; M von Wolff
Journal:  J Assist Reprod Genet       Date:  2017-01-10       Impact factor: 3.412

Review 3.  Does dienogest influence the inflammatory response of endometriotic cells? A systematic review.

Authors:  Giovanni Grandi; Michael Mueller; Nick A Bersinger; Angelo Cagnacci; Annibale Volpe; Brett McKinnon
Journal:  Inflamm Res       Date:  2015-12-09       Impact factor: 4.575

4.  Estradiol is a critical mediator of macrophage-nerve cross talk in peritoneal endometriosis.

Authors:  Erin Greaves; Julia Temp; Arantza Esnal-Zufiurre; Sylvia Mechsner; Andrew W Horne; Philippa T K Saunders
Journal:  Am J Pathol       Date:  2015-06-12       Impact factor: 4.307

5.  Enhanced inflammatory activity of endometriotic lesions from the rectovaginal septum.

Authors:  Dominic Bertschi; Brett D McKinnon; Jakob Evers; Nick A Bersinger; Michael D Mueller
Journal:  Mediators Inflamm       Date:  2013-12-28       Impact factor: 4.711

6.  Peritoneal Fluid Cytokines Reveal New Insights of Endometriosis Subphenotypes.

Authors:  Jieliang Zhou; Bernard Su Min Chern; Peter Barton-Smith; Jessie Wai Leng Phoon; Tse Yeun Tan; Veronique Viardot-Foucault; Chee Wai Ku; Heng Hao Tan; Jerry Kok Yen Chan; Yie Hou Lee
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

7.  Multiplex analysis of 40 cytokines do not allow separation between endometriosis patients and controls.

Authors:  Tamara Knific; Dmytro Fishman; Andrej Vogler; Manuela Gstöttner; René Wenzl; Hedi Peterson; Tea Lanišnik Rižner
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

8.  Interplay between Misplaced Müllerian-Derived Stem Cells and Peritoneal Immune Dysregulation in the Pathogenesis of Endometriosis.

Authors:  Antonio Simone Laganà; Emanuele Sturlese; Giovanni Retto; Vincenza Sofo; Onofrio Triolo
Journal:  Obstet Gynecol Int       Date:  2013-06-13

9.  Increased expression of pattern recognition receptors and nitric oxide synthase in patients with endometriosis.

Authors:  Seung Geun Yeo; Yong Sung Won; Ho Yun Lee; Young Il Kim; Jin-Woo Lee; Dong Choon Park
Journal:  Int J Med Sci       Date:  2013-07-30       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.